Skip to main content
Signal8

Sharps Technology Inc. (STSS) Form 10-Q — May 14, 2026

$STSSForm 10-QFiled May 14, 2026, 5:30 PM ET0001493152-26-023214Original filing

Sharps Technology reported a net loss of $86.2 million for the first quarter of 2026, driven by a $70.8 million unrealized loss and $10.8 million realized loss on its Solana (SOL) treasury holdings. The company’s total assets declined from $269 million to $181 million, reflecting the sharp drop in SOL market value, while cash reserves stood at $12.3 million. The company generated only $192,780 in traditional medical device revenue but recognized $3.1 million in staking revenue from its SOL holdings. Operating expenses were elevated at $89.4 million, including $2.5 million in related-party consulting fees and $2.2 million in stock-based compensation.

Key figures

Revenue
192780
Total Debt
0
Total Assets
181002610
Cash Position
12320547
Staking Revenue
3134109
Cost Of Repurchases
1588861
Shares Repurchased
867678
Stock Based Compensation
2230208
Consulting Fees Related Party
2500000
Digital Commodities Fair Value
162490274

Price after filing

1 day: -6.0%7 days: -5.5%30 days: -43.5%

Close on the filing date to close N calendar days later (from $2.00). Historical, not a forecast.

AI analysis

Red flags6 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    Sharps Technology Inc. (STSS) Form 10-Q — May 14, 2026: AI Analysis | Signal8